Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL523P is a human pseudogene whose sequence is derived from the 7SL RNA, a noncoding RNA that serves as the scaffold for the signal recognition particle (SRP). The SRP, containing 7SL RNA, facilitates targeting of nascent secretory and membrane proteins to the endoplasmic reticulum during translation. However, RN7SL523P itself is a truncated and inactive genomic copy, lacking evidence for functional transcription, protein expression, or direct biological/clinical significance. Most 7SL pseudogenes result from reverse transcription events and do not encode active molecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 523, pseudogene (RN7SL523P).